Regulatory reviewers rarely ask whether an adhesive bonds well — they ask for documentation proving it was tested to a recognized standard, and cyanoacrylate for disposable device-component assembly is judged on that paper trail as much as on bond strength.

The Compliance Baseline: What “Formulated to Meet ISO 10993-5” Actually Means

Incure’s Cyro-Weld CM-series and 5000-series cyanoacrylates intended for external, disposable device-component bonding are formulated to meet ISO 10993-5, the biological evaluation standard covering in vitro cytotoxicity. Passing that evaluation means the cured adhesive does not release compounds at levels that damage cell cultures under the standard’s test protocol — a baseline check, not a blanket safety claim for every possible application. It is one input into a device manufacturer’s broader biological evaluation, not a substitute for it, and it applies specifically to external and disposable component bonding rather than any implantable use.

Building the Documentation Package

A usable compliance package for this category typically includes four elements: the ISO 10993-5 test summary itself, a certificate of analysis tying that result to a specific lot and formulation, a statement of sterilization compatibility (see below), and a material safety data sheet current to the applicable regulation. Missing any one of these is a common cause of delay when a device manufacturer submits its own documentation package, since reviewers generally want the adhesive’s paperwork to trace cleanly back to the lot actually used in the validated device.

Sterilization Validation: A Second, Separate Test

Biocompatibility testing and sterilization-compatibility testing answer two different questions, and a formulation can pass one without the other. Cyanoacrylate for disposable device components is commonly validated for ethylene oxide (EtO) and gamma sterilization specifically — meaning post-sterilization samples are checked for bond-strength retention, discoloration, and embrittlement against the un-sterilized baseline. A formulation that meets ISO 10993-5 but was never run through the sterilization cycle a device actually uses has an incomplete documentation package, not a false one, but incomplete is still a rejection reason during a regulatory review.

What This Documentation Does Not Cover

It is worth being precise about scope: formulation to ISO 10993-5 and EtO/gamma validation supports external, disposable device-component bonding — connectors, hubs, housings, external tubing sets, and wearable sensor assemblies. It is not a claim of suitability for implantable or long-term internal contact use, which sits under a materially different and more extensive testing regime. A device manufacturer working on an implantable application needs a different conversation and a different documentation scope than the one covered here. Email Us to confirm which test package applies to your specific device-component application before finalizing a specification.

Viscosity and Cure Speed Still Matter for Process Validation

Compliance documentation answers the safety question, but a process validation still needs the adhesive’s viscosity and cure-speed data to lock in a repeatable dispense process. Low-viscosity Cyro-Weld grades such as CM-2 and CM-4, suited to wicking into a pre-assembled connector joint, and higher-viscosity gels such as CM-2500, suited to gap-filling on a housing seam, carry different cure-speed profiles, and a process validation protocol should be written against the specific grade’s data sheet, not a generic cyanoacrylate assumption. A structured grade comparison by viscosity and tensile requirement is a useful reference when the same assembly also uses a UV-cured joint elsewhere in the housing.

Reviewing Documentation Before It Reaches a Regulatory Submission

The most efficient point to catch a documentation gap is before it reaches a regulatory submission, not after a reviewer flags it. Cross-checking the adhesive’s ISO 10993-5 summary, sterilization-validation statement, and lot-specific certificate of analysis against the device’s own test plan — ideally with the material supplier involved directly — closes most gaps early. Where a joint elsewhere in the same assembly could use a stronger structural bond instead of cyanoacrylate, comparing bond strength for heavy-duty repairs against a two-part system is worth doing at the design stage, before the documentation package is locked.

Lot Traceability Across the Supply Chain

A compliance package is only as strong as its weakest traceability link, and for a disposable device-component adhesive that link is often the connection between the certificate of analysis and the specific production lot actually used on the assembly line. A device manufacturer’s own quality system should be able to trace a finished, sterilized unit back to the exact adhesive lot, cure-station settings, and inspection records used to build it — and an adhesive supplier that cannot provide lot-specific documentation on request creates a traceability gap that shows up during an internal audit or an external regulatory inspection, not necessarily at the time of purchase. Confirming this traceability chain before qualifying a supplier, rather than after a device is already in production, is a standard part of a mature quality system.

Change Control When a Formulation Is Updated

Adhesive formulations occasionally change — a raw-material substitution, a manufacturing-process update, or a minor reformulation to improve a secondary property. Any such change can, in principle, affect biocompatibility or sterilization-compatibility results even when the change seems unrelated to those properties on paper. A documentation package that includes a clear change-control history, showing when and why a formulation was updated and whether biocompatibility or sterilization testing was repeated after the change, protects a device manufacturer from unknowingly building a submission around outdated test data. Requesting this history as part of supplier qualification closes a gap that is easy to overlook when a formulation has been in use for years without an obvious change.

Getting the Paper Trail Right

A technically sound adhesive with an incomplete compliance file is still, from a regulatory reviewer’s perspective, an unproven one. Treating the ISO 10993-5 summary, the sterilization-validation data, and the lot traceability as part of the specification — not an afterthought once the adhesive is already in production — saves real time during submission review. Contact Our Team to request the documentation package for a specific grade and sterilization method.

Visit www.incurelab.com for more information.